Pretreatment of leukemic cells with low-dose decitabine markedly enhances the cytotoxicity of gemtuzumab ozogamicin

por Kurimoto, M, Matsuoka, H, Hanaoka, N, Uneda, S, Murayama, T, Sonoki, T, Nakakuma, H
Publicado 2013